Question
Zila, Inc. is an international provider of pharmaceutical, biotechnology, and nutraceutical products for dental/medical professionals and consumers. One of Zilas recent major projects is a
Zila, Inc. is an international provider of pharmaceutical, biotechnology, and nutraceutical products for dental/medical professionals and consumers. One of Zila’s recent major projects is a method to detect oral cancer for which Zila is awaiting FDA approval on. Captions of their statement of operations, balance sheet, and cash flow are presented below.
Selected Balance Sheet Data
2001 | 2000 | |
Cash and cash equivalents | $1,651,266 | $5,558,487 |
Accounts receivable, net of allowance of $312,061 (2001) and $345,857 (2000) | 10,412,372 | 9,893,587 |
Inventories | 17,751,148 | 13,204,137 |
Total current assets | 32,069,550 | 31,380,071 |
Property & equipment (net) | 9,843,103 | 9,442,278 |
Total assets | 76,557,129 | 77,711,459 |
Total current liabilities | 15,683,253 | 11,050,668 |
Short-term borrowings | 6,160,947 | 51,770 |
Total debt | 19,836,524 | 15,599,621 |
Selected Income Statement Data
2001 | 2000 | 1999 | |
Net sales | $73,724,923 | $77,580,908 | $71,294,751 |
Cost of products sold | 41,425,083 | 40,004,391 | 34,355,344 |
Gross Profit | 32,299,840 | 37,576,517 | 36,939,407 |
Selling, general, and admin. expense | 31,864,041 | 32,449,161 | 31,853,421 |
Operating profit (loss) | (6,125,804) | 20,656 | (2,463,810) |
Interest expense | 596,870 | 2,112,671 | 392,805 |
Net income (loss) | (6,313,823) | 2,932,027 | (1,966,982) |
Selected Cash Flow Data
2001 | 2000 | 1999 | |
Net cash provided from operating activities | ($8,683,507) | $2,329,653 | ($791,581) |
You assemble the following ratios:
2000 | 2001 | Industry | |
Current ratio | 2.84% | 2.04% | 1.5% |
Quick ratio | 1.64% | 0.91% | 0.9% |
Average collection period | 46.55 days | 51.55 days | 50 days |
Days inventory held | 120.47 days | 156.41 days | 67 days |
Fixed asset turnover | 8.22X | 7.49X | 37.2X |
Total asset turnover | 1.00X | 0.96X | 2.6X |
Debt to total assets | 20% | 26% | 65.3% |
Times interest earned | 0.01X | -10.26X | 3.4X |
Gross profit margin | 48.44% | 43.81% | 30.6% |
Operating profit margin | 0.03% | -8.31% | 5.2% |
Answer the following questions;
Industry ratios from Robert Morris Associates, Annual Statement Studies, 2001; SIC #5047
Comment on the firm’s liquidity position in terms of the current and quick ratios. Which of the two ratios is deteriorating more? What does this imply?
Comment on the average collection period.
The management of which current asset(s) would be of most concern to the financial analyst? Explain.
Zila’s total debt has risen since 2000. Is their capital structure more or less risky than the industry? Explain.
What concerns would creditors have about their stake in Zila?
Discuss the company’s profitability.
Given the overall circumstances surrounding Zila, list two reasons for and two reasons against making an investment in Zila.
Step by Step Solution
3.50 Rating (153 Votes )
There are 3 Steps involved in it
Step: 1
Comment on the firms liquidity position in terms of the current and quick ratios Which of the two ratios is deteriorating more What does this imply The firms liquidity position has deteriorated since ...Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started